Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.97 |
| ▸ | KCNN2 | Q9H2S1 | 4/20 | 0.63 |
| ▸ | KCNN3 | Q9UGI6 | 4/20 | 0.63 |
| ▸ | KCNN1 | Q92952 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | BRD4 | O60885 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19888927 | 1.00 | MAOA (0.97) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL29382740 | 1.00 | MAOA (0.97) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL18256759 | 0.89 | MAOA (0.77) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL24039929 | 0.87 | MAOA (0.75) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL14739491 | 0.87 | MAOA (0.86) | MAOAMAPK1 | |
| SCHEMBL26956106 | 0.87 | MAOA (0.75) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL8034415 | 0.87 | MAOA (0.97) | MAOASMN1; SMN2KDM4EALDH1A1HSD17B10 | |
| SCHEMBL27156518 | 0.87 | MAOA (0.75) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL29515907 | 0.87 | MAOA (0.75) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 | |
| SCHEMBL21255942 | 0.86 | MAOA (0.72) | MAOAKCNN2KCNN3KCNN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| CN-113157912-A | Text classification method based on machine learning | 航天科工网络信息发展有限公司 | 2021-07-23 | — | — | CN | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| US-9902699-B2 | Synthesis of tetrahydroisoquinolines from 2-methyl-1-phenyl substituted indenes | Gregory Rosocha (CA) | 2018-02-27 | — | — | US | disclosed |
| CN-104561007-A | Lymantria dispar linnaeus CYP6B53 gene dsRNA and application thereof in nuisanceless control | UNIV NORTHEAST FORESTRY | 2015-04-29 | — | — | CN | disclosed |
| US-20110114075-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. | 2011-05-19 | — | — | US | disclosed |
| EP-2318307-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | Blacklight Power, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010014684-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BLACKLIGHT POWER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| EP-2119434-A1 | Use of heterosidic flavonoid derivatives for therapy of stem cell cancers | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-11-18 | — | — | EP | disclosed |
| US-5272270-A | Process for the preparation of 1-alkylisoquinoline derivatives | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1993-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | MAOA 1925/4885KCNN2 252/4885KCNN3 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.